Search clinical trials for: GSK221149A

Total 4 results

GlaxoSmithKline

Completed

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Obstetric Labour, Premature

United States, France, Bulgaria, Spain, Korea, Republic of, Singapore, Colombia, United Kingdom, Lithuania, Puerto Rico, Argentina
GlaxoSmithKline

Completed

Absorption, Distribution, Metabolism And Excretion Study For GSK221149A

Obstetric Labour, Premature | Premature Labor

United States
GlaxoSmithKline

Terminated

A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects

Premature Ejaculation | Obstetric Labour, Premature

United States
GlaxoSmithKline

Completed

A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole

Obstetric Labour, Premature

United States

3

Subscribe